nodes	percent_of_prediction	percent_of_DWPC	metapath
Emtricitabine—Decitabine—DNMT1—brain cancer	0.0407	0.737	CrCbGaD
Emtricitabine—Osteonecrosis—Procarbazine—brain cancer	0.0358	0.0379	CcSEcCtD
Emtricitabine—Skin hyperpigmentation—Procarbazine—brain cancer	0.0224	0.0237	CcSEcCtD
Emtricitabine—Opportunistic infection—Temozolomide—brain cancer	0.02	0.0212	CcSEcCtD
Emtricitabine—Skin hyperpigmentation—Hydroxyurea—brain cancer	0.0173	0.0184	CcSEcCtD
Emtricitabine—Zalcitabine—CYP2C9—brain cancer	0.0145	0.263	CrCbGaD
Emtricitabine—Skin hyperpigmentation—Carmustine—brain cancer	0.014	0.0148	CcSEcCtD
Emtricitabine—Neuropathy—Procarbazine—brain cancer	0.0125	0.0132	CcSEcCtD
Emtricitabine—Renal failure—Lomustine—brain cancer	0.0115	0.0122	CcSEcCtD
Emtricitabine—Myopathy—Temozolomide—brain cancer	0.0115	0.0122	CcSEcCtD
Emtricitabine—Creatinine increased—Hydroxyurea—brain cancer	0.0108	0.0115	CcSEcCtD
Emtricitabine—Otitis media—Temozolomide—brain cancer	0.0104	0.011	CcSEcCtD
Emtricitabine—Rash maculo-papular—Hydroxyurea—brain cancer	0.00938	0.00993	CcSEcCtD
Emtricitabine—Hyperbilirubinaemia—Temozolomide—brain cancer	0.00886	0.00938	CcSEcCtD
Emtricitabine—Infection—Carboplatin—brain cancer	0.00851	0.009	CcSEcCtD
Emtricitabine—Pancreatitis—Procarbazine—brain cancer	0.0082	0.00868	CcSEcCtD
Emtricitabine—Renal failure acute—Hydroxyurea—brain cancer	0.00811	0.00859	CcSEcCtD
Emtricitabine—Dermatitis bullous—Hydroxyurea—brain cancer	0.00784	0.00829	CcSEcCtD
Emtricitabine—Neuropathy—Carmustine—brain cancer	0.00783	0.00829	CcSEcCtD
Emtricitabine—Neuropathy—Temozolomide—brain cancer	0.00757	0.00801	CcSEcCtD
Emtricitabine—Pneumonia—Procarbazine—brain cancer	0.0075	0.00794	CcSEcCtD
Emtricitabine—Infection—Lomustine—brain cancer	0.00744	0.00788	CcSEcCtD
Emtricitabine—Thrombocytopenia—Lomustine—brain cancer	0.00733	0.00776	CcSEcCtD
Emtricitabine—Pain—Carboplatin—brain cancer	0.00732	0.00775	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Procarbazine—brain cancer	0.00731	0.00774	CcSEcCtD
Emtricitabine—Skin discolouration—Etoposide—brain cancer	0.00714	0.00756	CcSEcCtD
Emtricitabine—Haematuria—Procarbazine—brain cancer	0.00711	0.00753	CcSEcCtD
Emtricitabine—Blood creatinine increased—Hydroxyurea—brain cancer	0.00702	0.00743	CcSEcCtD
Emtricitabine—Body temperature increased—Carboplatin—brain cancer	0.00677	0.00716	CcSEcCtD
Emtricitabine—Breast disorder—Hydroxyurea—brain cancer	0.00677	0.00716	CcSEcCtD
Emtricitabine—Inflammation—Etoposide—brain cancer	0.00665	0.00704	CcSEcCtD
Emtricitabine—Gastroenteritis—Temozolomide—brain cancer	0.0066	0.00699	CcSEcCtD
Emtricitabine—Pancreatitis—Hydroxyurea—brain cancer	0.00635	0.00672	CcSEcCtD
Emtricitabine—Neuropathy—Etoposide—brain cancer	0.00606	0.00641	CcSEcCtD
Emtricitabine—Neutropenia—Hydroxyurea—brain cancer	0.00605	0.00641	CcSEcCtD
Emtricitabine—Body temperature increased—Lomustine—brain cancer	0.00592	0.00627	CcSEcCtD
Emtricitabine—Rash maculo-papular—Etoposide—brain cancer	0.00586	0.0062	CcSEcCtD
Emtricitabine—Infestation—Hydroxyurea—brain cancer	0.00577	0.00611	CcSEcCtD
Emtricitabine—Infestation NOS—Hydroxyurea—brain cancer	0.00577	0.00611	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Hydroxyurea—brain cancer	0.00566	0.00599	CcSEcCtD
Emtricitabine—Hypokalaemia—Carmustine—brain cancer	0.00551	0.00583	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Hydroxyurea—brain cancer	0.00546	0.00578	CcSEcCtD
Emtricitabine—Anaemia—Procarbazine—brain cancer	0.00539	0.0057	CcSEcCtD
Emtricitabine—Muscular weakness—Carmustine—brain cancer	0.00534	0.00565	CcSEcCtD
Emtricitabine—Hypokalaemia—Temozolomide—brain cancer	0.00532	0.00564	CcSEcCtD
Emtricitabine—Breast disorder—Temozolomide—brain cancer	0.00529	0.0056	CcSEcCtD
Emtricitabine—Muscular weakness—Temozolomide—brain cancer	0.00516	0.00546	CcSEcCtD
Emtricitabine—Alanine aminotransferase increased—Temozolomide—brain cancer	0.00516	0.00546	CcSEcCtD
Emtricitabine—Cough—Procarbazine—brain cancer	0.00509	0.00538	CcSEcCtD
Emtricitabine—Arthralgia—Procarbazine—brain cancer	0.00496	0.00525	CcSEcCtD
Emtricitabine—Myalgia—Procarbazine—brain cancer	0.00496	0.00525	CcSEcCtD
Emtricitabine—Anxiety—Procarbazine—brain cancer	0.00494	0.00523	CcSEcCtD
Emtricitabine—Neutropenia—Carmustine—brain cancer	0.00489	0.00518	CcSEcCtD
Emtricitabine—Vomiting—Lomustine—brain cancer	0.00476	0.00504	CcSEcCtD
Emtricitabine—Neutropenia—Temozolomide—brain cancer	0.00473	0.005	CcSEcCtD
Emtricitabine—Infection—Procarbazine—brain cancer	0.00472	0.005	CcSEcCtD
Emtricitabine—Hyperglycaemia—Carmustine—brain cancer	0.00472	0.005	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Temozolomide—brain cancer	0.0047	0.00497	CcSEcCtD
Emtricitabine—Pneumonia—Carmustine—brain cancer	0.00469	0.00497	CcSEcCtD
Emtricitabine—Thrombocytopenia—Procarbazine—brain cancer	0.00466	0.00493	CcSEcCtD
Emtricitabine—Depression—Carmustine—brain cancer	0.00465	0.00492	CcSEcCtD
Emtricitabine—Renal failure—Carmustine—brain cancer	0.00459	0.00485	CcSEcCtD
Emtricitabine—Weight decreased—Temozolomide—brain cancer	0.00457	0.00484	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Carmustine—brain cancer	0.00457	0.00484	CcSEcCtD
Emtricitabine—Hyperglycaemia—Temozolomide—brain cancer	0.00456	0.00483	CcSEcCtD
Emtricitabine—Urinary tract infection—Carmustine—brain cancer	0.00453	0.0048	CcSEcCtD
Emtricitabine—Pneumonia—Temozolomide—brain cancer	0.00453	0.0048	CcSEcCtD
Emtricitabine—Infestation NOS—Temozolomide—brain cancer	0.00451	0.00477	CcSEcCtD
Emtricitabine—Infestation—Temozolomide—brain cancer	0.00451	0.00477	CcSEcCtD
Emtricitabine—Depression—Temozolomide—brain cancer	0.0045	0.00476	CcSEcCtD
Emtricitabine—Nausea—Lomustine—brain cancer	0.00445	0.00471	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Temozolomide—brain cancer	0.00442	0.00468	CcSEcCtD
Emtricitabine—Urinary tract infection—Temozolomide—brain cancer	0.00438	0.00464	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00433	0.00459	CcSEcCtD
Emtricitabine—Insomnia—Procarbazine—brain cancer	0.0043	0.00455	CcSEcCtD
Emtricitabine—Paraesthesia—Procarbazine—brain cancer	0.00427	0.00452	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Temozolomide—brain cancer	0.00426	0.00451	CcSEcCtD
Emtricitabine—Sinusitis—Temozolomide—brain cancer	0.00423	0.00448	CcSEcCtD
Emtricitabine—Anaemia—Hydroxyurea—brain cancer	0.00417	0.00441	CcSEcCtD
Emtricitabine—Alanine aminotransferase increased—Etoposide—brain cancer	0.00413	0.00437	CcSEcCtD
Emtricitabine—Connective tissue disorder—Carmustine—brain cancer	0.00412	0.00436	CcSEcCtD
Emtricitabine—Fatigue—Procarbazine—brain cancer	0.0041	0.00434	CcSEcCtD
Emtricitabine—Pain—Procarbazine—brain cancer	0.00407	0.0043	CcSEcCtD
Emtricitabine—Hepatitis—Temozolomide—brain cancer	0.00405	0.00428	CcSEcCtD
Emtricitabine—Pharyngitis—Temozolomide—brain cancer	0.00402	0.00425	CcSEcCtD
Emtricitabine—Urinary tract disorder—Temozolomide—brain cancer	0.004	0.00423	CcSEcCtD
Emtricitabine—Connective tissue disorder—Temozolomide—brain cancer	0.00398	0.00421	CcSEcCtD
Emtricitabine—Urethral disorder—Temozolomide—brain cancer	0.00397	0.0042	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Procarbazine—brain cancer	0.00389	0.00412	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00381	0.00404	CcSEcCtD
Emtricitabine—Neutropenia—Etoposide—brain cancer	0.00378	0.004	CcSEcCtD
Emtricitabine—Urticaria—Procarbazine—brain cancer	0.00378	0.004	CcSEcCtD
Emtricitabine—Abdominal pain—Procarbazine—brain cancer	0.00376	0.00398	CcSEcCtD
Emtricitabine—Body temperature increased—Procarbazine—brain cancer	0.00376	0.00398	CcSEcCtD
Emtricitabine—Mental disorder—Carmustine—brain cancer	0.00367	0.00388	CcSEcCtD
Emtricitabine—Infection—Hydroxyurea—brain cancer	0.00366	0.00387	CcSEcCtD
Emtricitabine—Immune system disorder—Temozolomide—brain cancer	0.00366	0.00387	CcSEcCtD
Emtricitabine—Mediastinal disorder—Temozolomide—brain cancer	0.00365	0.00386	CcSEcCtD
Emtricitabine—Malnutrition—Carmustine—brain cancer	0.00365	0.00386	CcSEcCtD
Emtricitabine—Pneumonia—Etoposide—brain cancer	0.00363	0.00384	CcSEcCtD
Emtricitabine—Nervous system disorder—Hydroxyurea—brain cancer	0.00361	0.00382	CcSEcCtD
Emtricitabine—Infestation—Etoposide—brain cancer	0.00361	0.00382	CcSEcCtD
Emtricitabine—Infestation NOS—Etoposide—brain cancer	0.00361	0.00382	CcSEcCtD
Emtricitabine—Thrombocytopenia—Hydroxyurea—brain cancer	0.0036	0.00381	CcSEcCtD
Emtricitabine—Skin disorder—Hydroxyurea—brain cancer	0.00358	0.00378	CcSEcCtD
Emtricitabine—Renal failure—Etoposide—brain cancer	0.00355	0.00375	CcSEcCtD
Emtricitabine—Mental disorder—Temozolomide—brain cancer	0.00355	0.00375	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Etoposide—brain cancer	0.00354	0.00374	CcSEcCtD
Emtricitabine—Back pain—Carmustine—brain cancer	0.00353	0.00373	CcSEcCtD
Emtricitabine—Malnutrition—Temozolomide—brain cancer	0.00352	0.00373	CcSEcCtD
Emtricitabine—Hypersensitivity—Procarbazine—brain cancer	0.0035	0.00371	CcSEcCtD
Emtricitabine—Asthenia—Procarbazine—brain cancer	0.00341	0.00361	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Etoposide—brain cancer	0.00341	0.00361	CcSEcCtD
Emtricitabine—Back pain—Temozolomide—brain cancer	0.00341	0.00361	CcSEcCtD
Emtricitabine—Anaemia—Carmustine—brain cancer	0.00337	0.00357	CcSEcCtD
Emtricitabine—Pruritus—Procarbazine—brain cancer	0.00336	0.00356	CcSEcCtD
Emtricitabine—Dyspnoea—Hydroxyurea—brain cancer	0.00328	0.00347	CcSEcCtD
Emtricitabine—Anaemia—Temozolomide—brain cancer	0.00326	0.00345	CcSEcCtD
Emtricitabine—Diarrhoea—Procarbazine—brain cancer	0.00325	0.00344	CcSEcCtD
Emtricitabine—Dyspepsia—Hydroxyurea—brain cancer	0.00324	0.00343	CcSEcCtD
Emtricitabine—Angioedema—Temozolomide—brain cancer	0.00322	0.00341	CcSEcCtD
Emtricitabine—Urinary tract disorder—Etoposide—brain cancer	0.0032	0.00339	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00318	0.00336	CcSEcCtD
Emtricitabine—Urethral disorder—Etoposide—brain cancer	0.00317	0.00336	CcSEcCtD
Emtricitabine—Fatigue—Hydroxyurea—brain cancer	0.00317	0.00336	CcSEcCtD
Emtricitabine—Pain—Hydroxyurea—brain cancer	0.00315	0.00333	CcSEcCtD
Emtricitabine—Dizziness—Procarbazine—brain cancer	0.00315	0.00333	CcSEcCtD
Emtricitabine—Myalgia—Carmustine—brain cancer	0.0031	0.00329	CcSEcCtD
Emtricitabine—Anxiety—Carmustine—brain cancer	0.00309	0.00327	CcSEcCtD
Emtricitabine—Cough—Temozolomide—brain cancer	0.00307	0.00325	CcSEcCtD
Emtricitabine—Vomiting—Procarbazine—brain cancer	0.00302	0.0032	CcSEcCtD
Emtricitabine—Arthralgia—Temozolomide—brain cancer	0.003	0.00317	CcSEcCtD
Emtricitabine—Myalgia—Temozolomide—brain cancer	0.003	0.00317	CcSEcCtD
Emtricitabine—Rash—Procarbazine—brain cancer	0.003	0.00317	CcSEcCtD
Emtricitabine—Dermatitis—Procarbazine—brain cancer	0.003	0.00317	CcSEcCtD
Emtricitabine—Anxiety—Temozolomide—brain cancer	0.00299	0.00316	CcSEcCtD
Emtricitabine—Headache—Procarbazine—brain cancer	0.00298	0.00315	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00298	0.00315	CcSEcCtD
Emtricitabine—Infection—Carmustine—brain cancer	0.00296	0.00313	CcSEcCtD
Emtricitabine—Immune system disorder—Etoposide—brain cancer	0.00293	0.0031	CcSEcCtD
Emtricitabine—Mediastinal disorder—Etoposide—brain cancer	0.00292	0.00309	CcSEcCtD
Emtricitabine—Thrombocytopenia—Carmustine—brain cancer	0.00291	0.00308	CcSEcCtD
Emtricitabine—Body temperature increased—Hydroxyurea—brain cancer	0.00291	0.00308	CcSEcCtD
Emtricitabine—Infection—Temozolomide—brain cancer	0.00286	0.00302	CcSEcCtD
Emtricitabine—Nausea—Procarbazine—brain cancer	0.00283	0.00299	CcSEcCtD
Emtricitabine—Nervous system disorder—Temozolomide—brain cancer	0.00282	0.00298	CcSEcCtD
Emtricitabine—Thrombocytopenia—Temozolomide—brain cancer	0.00282	0.00298	CcSEcCtD
Emtricitabine—Skin disorder—Temozolomide—brain cancer	0.00279	0.00296	CcSEcCtD
Emtricitabine—Back pain—Etoposide—brain cancer	0.00273	0.00289	CcSEcCtD
Emtricitabine—Hypersensitivity—Hydroxyurea—brain cancer	0.00271	0.00287	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Carmustine—brain cancer	0.00271	0.00287	CcSEcCtD
Emtricitabine—Insomnia—Carmustine—brain cancer	0.00269	0.00285	CcSEcCtD
Emtricitabine—Paraesthesia—Carmustine—brain cancer	0.00267	0.00283	CcSEcCtD
Emtricitabine—Dyspnoea—Carmustine—brain cancer	0.00265	0.00281	CcSEcCtD
Emtricitabine—Asthenia—Hydroxyurea—brain cancer	0.00264	0.0028	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00262	0.00277	CcSEcCtD
Emtricitabine—Anaemia—Etoposide—brain cancer	0.00261	0.00276	CcSEcCtD
Emtricitabine—Insomnia—Temozolomide—brain cancer	0.0026	0.00275	CcSEcCtD
Emtricitabine—Paraesthesia—Temozolomide—brain cancer	0.00258	0.00273	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Carmustine—brain cancer	0.00257	0.00272	CcSEcCtD
Emtricitabine—Dyspnoea—Temozolomide—brain cancer	0.00256	0.00271	CcSEcCtD
Emtricitabine—Pain—Carmustine—brain cancer	0.00254	0.00269	CcSEcCtD
Emtricitabine—Dyspepsia—Temozolomide—brain cancer	0.00253	0.00268	CcSEcCtD
Emtricitabine—Diarrhoea—Hydroxyurea—brain cancer	0.00252	0.00267	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Temozolomide—brain cancer	0.00248	0.00263	CcSEcCtD
Emtricitabine—Fatigue—Temozolomide—brain cancer	0.00248	0.00262	CcSEcCtD
Emtricitabine—Cough—Etoposide—brain cancer	0.00246	0.0026	CcSEcCtD
Emtricitabine—Pain—Temozolomide—brain cancer	0.00246	0.0026	CcSEcCtD
Emtricitabine—Dizziness—Hydroxyurea—brain cancer	0.00243	0.00258	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Carmustine—brain cancer	0.00243	0.00258	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.00238	0.00252	CcSEcCtD
Emtricitabine—Abdominal pain—Carmustine—brain cancer	0.00235	0.00249	CcSEcCtD
Emtricitabine—Body temperature increased—Carmustine—brain cancer	0.00235	0.00249	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Temozolomide—brain cancer	0.00235	0.00249	CcSEcCtD
Emtricitabine—Vomiting—Hydroxyurea—brain cancer	0.00234	0.00248	CcSEcCtD
Emtricitabine—Rash—Hydroxyurea—brain cancer	0.00232	0.00246	CcSEcCtD
Emtricitabine—Dermatitis—Hydroxyurea—brain cancer	0.00232	0.00245	CcSEcCtD
Emtricitabine—Headache—Hydroxyurea—brain cancer	0.00231	0.00244	CcSEcCtD
Emtricitabine—Infection—Etoposide—brain cancer	0.00229	0.00242	CcSEcCtD
Emtricitabine—Urticaria—Temozolomide—brain cancer	0.00228	0.00242	CcSEcCtD
Emtricitabine—Body temperature increased—Temozolomide—brain cancer	0.00227	0.00241	CcSEcCtD
Emtricitabine—Abdominal pain—Temozolomide—brain cancer	0.00227	0.00241	CcSEcCtD
Emtricitabine—Thrombocytopenia—Etoposide—brain cancer	0.00225	0.00238	CcSEcCtD
Emtricitabine—Skin disorder—Etoposide—brain cancer	0.00224	0.00237	CcSEcCtD
Emtricitabine—Hypersensitivity—Carmustine—brain cancer	0.00219	0.00232	CcSEcCtD
Emtricitabine—Nausea—Hydroxyurea—brain cancer	0.00219	0.00231	CcSEcCtD
Emtricitabine—Asthenia—Carmustine—brain cancer	0.00213	0.00226	CcSEcCtD
Emtricitabine—Hypersensitivity—Temozolomide—brain cancer	0.00212	0.00224	CcSEcCtD
Emtricitabine—Paraesthesia—Etoposide—brain cancer	0.00207	0.00219	CcSEcCtD
Emtricitabine—Asthenia—Temozolomide—brain cancer	0.00206	0.00218	CcSEcCtD
Emtricitabine—Dyspnoea—Etoposide—brain cancer	0.00205	0.00217	CcSEcCtD
Emtricitabine—Diarrhoea—Carmustine—brain cancer	0.00204	0.00215	CcSEcCtD
Emtricitabine—Pruritus—Temozolomide—brain cancer	0.00203	0.00215	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Etoposide—brain cancer	0.00199	0.0021	CcSEcCtD
Emtricitabine—Fatigue—Etoposide—brain cancer	0.00198	0.0021	CcSEcCtD
Emtricitabine—Dizziness—Carmustine—brain cancer	0.00197	0.00208	CcSEcCtD
Emtricitabine—Pain—Etoposide—brain cancer	0.00197	0.00208	CcSEcCtD
Emtricitabine—Diarrhoea—Temozolomide—brain cancer	0.00197	0.00208	CcSEcCtD
Emtricitabine—Dizziness—Temozolomide—brain cancer	0.0019	0.00201	CcSEcCtD
Emtricitabine—Vomiting—Carmustine—brain cancer	0.00189	0.002	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Etoposide—brain cancer	0.00188	0.00199	CcSEcCtD
Emtricitabine—Rash—Carmustine—brain cancer	0.00188	0.00199	CcSEcCtD
Emtricitabine—Dermatitis—Carmustine—brain cancer	0.00187	0.00198	CcSEcCtD
Emtricitabine—Headache—Carmustine—brain cancer	0.00186	0.00197	CcSEcCtD
Emtricitabine—Vomiting—Temozolomide—brain cancer	0.00183	0.00194	CcSEcCtD
Emtricitabine—Urticaria—Etoposide—brain cancer	0.00183	0.00193	CcSEcCtD
Emtricitabine—Abdominal pain—Etoposide—brain cancer	0.00182	0.00193	CcSEcCtD
Emtricitabine—Body temperature increased—Etoposide—brain cancer	0.00182	0.00193	CcSEcCtD
Emtricitabine—Rash—Temozolomide—brain cancer	0.00181	0.00192	CcSEcCtD
Emtricitabine—Dermatitis—Temozolomide—brain cancer	0.00181	0.00192	CcSEcCtD
Emtricitabine—Headache—Temozolomide—brain cancer	0.0018	0.00191	CcSEcCtD
Emtricitabine—Nausea—Carmustine—brain cancer	0.00177	0.00187	CcSEcCtD
Emtricitabine—Nausea—Temozolomide—brain cancer	0.00171	0.00181	CcSEcCtD
Emtricitabine—Hypersensitivity—Etoposide—brain cancer	0.0017	0.00179	CcSEcCtD
Emtricitabine—Asthenia—Etoposide—brain cancer	0.00165	0.00175	CcSEcCtD
Emtricitabine—Pruritus—Etoposide—brain cancer	0.00163	0.00172	CcSEcCtD
Emtricitabine—Diarrhoea—Etoposide—brain cancer	0.00157	0.00167	CcSEcCtD
Emtricitabine—Dizziness—Etoposide—brain cancer	0.00152	0.00161	CcSEcCtD
Emtricitabine—Vomiting—Etoposide—brain cancer	0.00146	0.00155	CcSEcCtD
Emtricitabine—Rash—Etoposide—brain cancer	0.00145	0.00154	CcSEcCtD
Emtricitabine—Dermatitis—Etoposide—brain cancer	0.00145	0.00153	CcSEcCtD
Emtricitabine—Headache—Etoposide—brain cancer	0.00144	0.00153	CcSEcCtD
Emtricitabine—Nausea—Etoposide—brain cancer	0.00137	0.00145	CcSEcCtD
